Generix
Market Cap
€108.5m
Last Updated
2019/11/11 20:57 UTC
Data Sources
Company Financials +
Executive Summary
Generix SA develops SaaS solutions for supply chain ecosystems.
Snowflake
Fundamentals
Proven track record with reasonable growth potential.
Similar Companies
Share Price & News
How has Generix's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: GENX has not had significant price volatility in the past 3 months.
Market Performance
7 Day Return
-5.6%
GENX
2.1%
FR Software
1.0%
FR Market
1 Year Return
37.0%
GENX
25.8%
FR Software
14.7%
FR Market
Return vs Industry: GENX exceeded the French Software industry which returned 25.8% over the past year.
Return vs Market: GENX exceeded the French Market which returned 14.7% over the past year.
Shareholder returns
| GENX | Industry | Market | |
|---|---|---|---|
| 7 Day | -5.6% | 2.1% | 1.0% |
| 30 Day | 0.4% | 1.0% | 3.9% |
| 90 Day | -1.2% | 6.7% | 8.4% |
| 1 Year | 37.0%37.0% | 26.6%25.8% | 18.5%14.7% |
| 3 Year | 61.9%61.9% | 94.1%90.2% | 50.9%36.4% |
| 5 Year | 129.6%129.6% | 167.1%154.8% | 72.3%47.4% |
Price Volatility Vs. Market
How volatile is Generix's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 day ago | Simply Wall St
Is Generix SA’s (EPA:GENX) 10% ROCE Any Good?3 weeks ago | Simply Wall St
Here's Why Generix (EPA:GENX) Can Manage Its Debt Responsibly1 month ago | Simply Wall St
Announcing: Generix (EPA:GENX) Stock Increased An Energizing 136% In The Last Five YearsValuation
Is Generix undervalued compared to its fair value and its price relative to the market?
44.4%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: GENX (€4.89) is trading below our estimate of fair value (€8.8)
Significantly Below Fair Value: GENX is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: GENX is poor value based on its PE Ratio (48.9x) compared to the Software industry average (34.4x).
PE vs Market: GENX is poor value based on its PE Ratio (48.9x) compared to the French market (18x).
Price to Earnings Growth Ratio
PEG Ratio: GENX is good value based on its PEG Ratio (0.9x)
Price to Book Ratio
PB vs Industry: GENX is overvalued based on its PB Ratio (3x) compared to the FR Software industry average (2.2x).
Next Steps
Future Growth
How is Generix forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
51.8%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: GENX's forecast earnings growth (51.8% per year) is above the savings rate (0.7%).
Earnings vs Market: GENX's earnings (51.8% per year) are forecast to grow faster than the French market (11.5% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: GENX's revenue (9.6% per year) is forecast to grow faster than the French market (4.6% per year).
High Growth Revenue: GENX's revenue (9.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if GENX's Return on Equity is forecast to be high in 3 years time
Next Steps
Past Performance
How has Generix performed over the past 5 years?
-39.0%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: GENX has high quality earnings.
Growing Profit Margin: GENX's current net profit margins (3%) are higher than last year (0.8%).
Past Earnings Growth Analysis
Earnings Trend: GENX's earnings have declined by -39% per year over the past 5 years.
Accelerating Growth: GENX's earnings growth over the past year (304.8%) exceeds its 5-year average (-39% per year).
Earnings vs Industry: GENX earnings growth over the past year (304.8%) exceeded the Software industry 2.3%.
Return on Equity
High ROE: GENX's Return on Equity (6.5%) is considered low.
Return on Assets
Return on Capital Employed
Next Steps
Financial Health
How is Generix's financial position?
Financial Position Analysis
Short Term Liabilities: GENX's short term assets (€47.7M) do not cover its short term liabilities (€48.8M)
Long Term Liabilities: GENX's short term assets (47.7M) exceeds its long term liabilities (13.6M)
Debt to Equity History and Analysis
Debt Level: GENX's debt to equity ratio (45%) is considered high
Reducing Debt: GENX's debt to equity ratio has increased from 13.6% to 45% over the past 5 years.
Debt Coverage: GENX's debt is well covered by operating cash flow (30.6%).
Interest Coverage: GENX's interest payments on its debt are well covered by EBIT (17.5x coverage).
Balance Sheet
Inventory Level: GENX has a low level of unsold assets or inventory.
Debt Coverage by Assets: GENX's debt is covered by short term assets (assets are 2.9x debt).
Next Steps
Dividend
What is Generix's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Current dividend yield vs market & industry
Notable Dividend: Unable to evaluate GENX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.
High Dividend: Unable to evaluate GENX's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if GENX's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if GENX's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of GENX's dividend in 3 years as they are not forecast to pay a notable one for the French market.
Next Steps
Management
What is the CEO of Generix's salary, the management and board of directors tenure and is there insider trading?
11.1yrs
Average board tenure
CEO
Aïda Sène 0
1.1yrs
Tenure
€370,280
Compensation
Aïda Collette-Sène has been Chief Executive Officer at Generix SA since October 2018.
CEO Compensation Analysis
Compensation vs Market: Aïda's total compensation ($USD408.70K) is above average for companies of similar size in the French market ($USD165.50K).
Compensation vs Earnings: Insufficient data to compare Aïda's compensation with company performance.
Board Age and Tenure
11.1yrs
Average Tenure
Experienced Board: GENX's board of directors are seasoned and experienced ( 11.1 years average tenure).
Insider Trading
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 21.4%.
Management Team
Jean-Charles Deconninck
Chairman of Management Board & President
- Tenure: 1.1yrs
- Compensation: €442.74k
Philippe Seguin
Chief Operating Officer
- Tenure: 0yrs
- Compensation: €596.19k
Christophe Verdenne
Chief Sales Officer
- Tenure: 0yrs
- Compensation: €259.99k
Ludovic Luzza
Chief Financial & Administrative Officer and Member of Management Board
- Tenure: 0yrs
- Compensation: €686.35k
Aïda Sène
Chief Executive Officer
- Tenure: 1.1yrs
- Compensation: €370.28k
Board Members
François Poirier (57yo)
Chairman of the Supervisory Board
- Tenure: 8.2yrs
- Compensation: €10.00k
Jean-François Gautier
Independent Member of Supervisory Board
- Tenure: 10.3yrs
- Compensation: €10.00k
Jean-Philippe Gallant (78yo)
Independent Member of the Supervisory Board
- Tenure: 14.8yrs
- Compensation: €10.00k
Gérard Claverie
Vice Chairman of Supervisory Board
- Tenure: 14yrs
- Compensation: €10.00k
Dominique Despiney
Independent Member of the Supervisory Board
- Tenure: 11.1yrs
- Compensation: €10.00k
Viviane Chaine-Ribeiro
Member of the Supervisory Board
- Tenure: 0yrs
- Compensation: €10.00k
Roland Bonnet
Member of Supervisory Board
- Tenure: 12yrs
- Compensation: €10.00k
Marie-Laure Bordais
Member of Supervisory Board
- Tenure: 8.2yrs
- Compensation: €10.00k
Company Information
Generix SA's company bio, employee growth, exchange listings and data sources
Key Information
- Name: Generix SA
- Ticker: GENX
- Exchange: ENXTPA
- Founded: 1990
- Industry: Application Software
- Sector: Software
- Market Cap: €108.470m
- Shares outstanding: 22.18m
- Website: https://www.generixgroup.com
Number of Employees
Location
- Generix SA
- ARTEPARC - Bât. A
- 2 rue des Peupliers
- Lesquin
- Nord-Pas-de-Calais
- 59810
- France
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| GENX | ENXTPA (Euronext Paris) | Yes | Ordinary Shares | FR | EUR | Jul 1998 |
| GENXP | BATS-CHIXE (BATS 'Chi-X Europe') | Yes | Ordinary Shares | GB | EUR | Jul 1998 |
Biography
Generix SA develops SaaS solutions for supply chain ecosystems. The company's supply chain hub platform offers supply chain execution solutions, including warehouse management software; transport managemen ...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2019/11/11 20:57 |
| End of Day Share Price | 2019/11/11 00:00 |
| Earnings | 2019/03/31 |
| Annual Earnings | 2019/03/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.